Urinary Tract Infections in Men: Causes, Symptoms & Treatment

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making health decisions based on this content.

By TriCountyUrology.org Editorial Team | Last verified: August 2026

What Is a Urinary Tract Infection in Men?

A urinary tract infection (UTI) in men is a bacterial or fungal infection affecting any part of the urinary system: the kidneys, ureters, bladder, or urethra. UTIs are classified into two categories based on location:

Lower Urinary Tract Infections in Men

Cystitis (bladder infection) and urethritis (urethra infection) are considered lower UTIs. These typically cause localized urinary symptoms and are generally less serious than upper UTIs, though they still require prompt treatment.

Upper Urinary Tract Infections in Men

Pyelonephritis (kidney infection) is an upper UTI that occurs when bacteria spread from the lower urinary tract or travel through the bloodstream. These infections carry greater risk for systemic complications and require more aggressive treatment.

While approximately 400 million UTI cases occur globally each year, they are significantly less common in men than in women. In fact, the presence of a UTI in a man often signals an underlying urological problem such as urinary obstruction, neurogenic bladder, or structural abnormality that requires investigation beyond treating the infection itself.

How Urinary Tract Infections Develop in Men

Primary Causative Organisms

Pathogenic Escherichia coli (E. coli) bacteria from the gastrointestinal tract cause approximately 75% of uncomplicated UTIs in men. Other common pathogens include Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa. Viral or fungal infections are rare but can occur in immunocompromised individuals or those with indwelling catheters.

Mechanism of Infection

Bacteria typically enter the urinary tract through the urethra and ascend toward the bladder. In men, the longer urethra (approximately 8–9 inches) and natural antibacterial properties of prostatic secretions provide protective barriers that make ascending infection less likely than in women. When these defenses fail—through obstruction, incomplete bladder emptying, or catheter use—infection becomes possible.

Risk Factors for Male UTIs

Understanding risk factors is critical because UTIs in men are uncommon and warrant evaluation:

• Urinary obstruction: Benign prostatic hyperplasia (BPH), strictures, or stones impede urine flow
• Neurogenic bladder: Spinal cord injury, diabetes, or Parkinson's disease impairs bladder emptying
• Urinary catheterization: Indwelling catheters bypass natural defenses and introduce pathogens
• Urinary retention: Delaying urination allows bacterial proliferation
• Diabetes: Elevated glucose in urine promotes bacterial growth and impairs immune response
• Immunosuppression: HIV, organ transplant, or chemotherapy reduce infection-fighting capacity
• Prostatitis: Chronic prostate inflammation can harbor bacteria
• Recent urological instrumentation: Cystoscopy or catheter placement introduces bacteria
• Poor genital hygiene: Increases bacterial colonization
• Dehydration: Reduced urine output concentrates bacteria and irritates the urothelium

What the Research Shows About Male UTIs

Epidemiology and Prevalence

UTIs occur in approximately 5–8% of men over age 70 and are uncommon in younger males (less than 1%). When they do occur in younger men, infection typically indicates an underlying structural or functional abnormality. Research consistently demonstrates that the appearance of a UTI in a man should trigger investigation beyond routine antibiotic treatment (Evidence Grade: B).

Diagnostic Evidence

Clinical diagnosis of male UTI requires both symptoms and laboratory confirmation. Studies show that:

• Urine culture is the gold standard for diagnosis and should be obtained before antibiotic treatment when possible (Evidence Grade: A)
• Urinalysis showing pyuria (white blood cells) and bacteriuria supports clinical diagnosis
• Asymptomatic bacteriuria in men generally does not require treatment except in pregnancy-related contexts or before urological procedures (Evidence Grade: A)
• Imaging studies (ultrasound, CT) should be considered if recurrent infections occur or if initial presentation suggests upper UTI with systemic symptoms

Treatment Outcomes

Evidence-based treatment shows:

• Uncomplicated cystitis responds to 7–14 days of oral antibiotics (fluoroquinolones, trimethoprim-sulfamethoxazole, or cephalosporins depending on resistance patterns) (Evidence Grade: A)
• Pyelonephritis may require hospitalization and intravenous antibiotics, especially with fever, systemic toxicity, or vomiting (Evidence Grade: A)
• Symptom resolution typically occurs within 48–72 hours of appropriate antibiotic therapy; persistent symptoms warrant repeat culture and imaging
• Antibiotic resistance is increasing; local antibiogram data should guide initial therapy (Evidence Grade: B)

Clinical Presentation and Symptoms of Male UTI

Lower Urinary Tract Infection Symptoms

Men with cystitis or urethritis typically experience:

• Dysuria (burning or pain during urination)
• Urinary frequency and urgency
• Suprapubic discomfort or lower abdominal pain
• Occasionally, hematuria (blood in urine) or purulent discharge from the urethra

Upper Urinary Tract Infection Symptoms

Pyelonephritis presents with systemic features in addition to lower urinary symptoms:

• Fever (often 101–104°F or higher)
• Costovertebral angle (CVA) tenderness or flank pain
• Nausea and vomiting
• Malaise and chills
• In severe cases, signs of sepsis (hypotension, altered mental status, tachycardia)

Atypical Presentations

Elderly men, those with diabetes, or immunocompromised individuals may present with vague symptoms such as generalized weakness, confusion, or functional decline without typical urinary symptoms. This can delay diagnosis and increase risk of serious complications.

Forms and Diagnostic Considerations

There are no “forms” of UTI in the supplement sense; rather, diagnosis relies on clinical assessment and laboratory confirmation. Key diagnostic tests include:

Urinalysis

A first-void urinalysis should be obtained and assessed for nitrites (suggesting gram-negative bacteria like E. coli), leukocyte esterase (indicating white blood cell presence), and microscopy showing bacteriuria and pyuria. Dipstick findings alone, however, are not sufficient for diagnosis.

Urine Culture

Culture is the diagnostic gold standard. A clean-catch midstream specimen or straight catheterization should yield significant growth (typically ≥10⁵ CFU/mL for symptomatic men, or ≥10²–10⁴ CFU/mL in catheterized specimens). Culture allows organism identification and antibiotic susceptibility testing, enabling targeted therapy and detection of resistance patterns.

Imaging

Renal ultrasound or CT imaging may be indicated to evaluate for obstructing lesions, abscess formation, or structural abnormalities, especially in men with recurrent infections or pyelonephritis.

Safety and Side Effects of Antibiotic Treatment

Drug Interactions

Important interactions include:

• Fluoroquinolones reduce warfarin metabolism, increasing bleeding risk
• TMP-SMX increases methotrexate and digoxin levels
• NSAIDs combined with fluoroquinolones increase risk of CNS effects
• Antacids and iron supplements reduce fluoroquinolone absorption

Antibiotic Resistance Considerations

Rising resistance to fluoroquinolones and TMP-SMX in E. coli has prompted guidance toward empirical cephalosporin use or culture-guided therapy in many regions. Always verify local resistance patterns and obtain culture results when possible before finalizing treatment choice (Evidence Grade: B).

Prevention Strategies for Male UTI Recurrence

Lifestyle Modifications

• Adequate hydration: Maintaining urine output reduces bacterial concentration
• Complete bladder emptying: Avoid urinary retention; establish regular voiding schedules
• Good hygiene: Wash genital area regularly; urinate after sexual activity if applicable
• Diabetes management: Tight glucose control reduces UTI risk

Medical Interventions for Recurrent Infection

For men with recurrent UTIs (three or more in 12 months) despite lifestyle modification:

• Methenamine hippurate or mandelate: May reduce recurrence in men without upper UTI history (Evidence Grade: B)
• Long-term low-dose prophylactic antibiotics: Reserved for selected cases when other interventions fail; increases resistance risk (Evidence Grade: B)
• Urological evaluation: Essential to identify and treat underlying obstruction, stones, or structural abnormality

Key Takeaway

This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.